Maarten E Tushuizen is an expert in Gastroenterology at Leiden University Medical Center (Netherlands). As of October 2026, ScienceLeadR ranks Maarten E Tushuizen in the top 1% of experts in the Netherlands for MASH. Maarten E Tushuizen has authored 154 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 6 of them ongoing. SLR score: 690 (community average: 125). How the SLR is computed.

LeadR Profile

Maarten E Tushuizen Leiden University Medical Center Netherlands
690 ScienceLeadR Reputation 690
Network Map

Gastroenterology

Subspecialties: Hepatology - Transplantation - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Leiden University Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 154

Citations

Citations: 5 078 1st author: 14 Last author: 14 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Liver, Portal, and Systemic Thyroid Hormone Concentrations in End-Stage MASH Reveal Distinct Roles for T3/rT3 Ratio and T4.
PMID 42558035 — thyroid diseases, triiodothyronine, reverse, iodide peroxidase, non-alcoholic fatty liver disease, triiodothyronine, thyroid gland, liver, hormones, tissues, thyroid hormones, plasma
Thyroid20260
Rationale and design of a prospective cohort study and biobank of the offspring born to mothers with a solid organ transplant: protocol for the TransplantLines Next Generation study.
PMID 42481191 — pregnancy, mothers, blood, blood pressure, cohort studies, kidney, liver, pancreas, transplants, transplantation
BMJ Open20260
Increasing incidence and changing trends in etiology & survival rates in HCC in a European cohort.
PMID 42336243 — liver diseases, registries, mortality, epidemiology, incidence, global health, probability, neoplasms, liver, neoplasm metastasis, risk factors, therapeutics, survival rate
JHEP Rep20262
Validated early detection metrics reduce the population requiring liver fibrosis screening.
PMID 42297049 — epidemiology, fibrosis, liver, prevalence
Gastroenterology20264
Beyond Awareness: A Qualitative Assessment of Barriers and Facilitators to Implementing Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathways in Primary Care.
PMID 42293778 — liver diseases, liver
Gastro Hep Adv20261

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 6
Phase 4 3
Phase 2 2
Phase 3 1

By status:

Recruiting 4
Completed 3
Unknown 3
Not yet recruiting 2

By type:

Interventional 10
Observational 2

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 0
multicentric5to9 1
multicentricup10 5

Main Topics

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
How Differences in the Composition of Microorganisms in the Soil Affect the Microorganisms in the Human Gut Through the Vegetables That Grow in it a Process Pilot Study With Healthy Participants
NCT07742319 — pilot projects, pilots, soil, healthy volunteers, metagenomics, vegetables, biodiversity, gastrointestinal microbiome
N/ANot yet recruiting2026
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction Associated Steatotic Liver Disease (SYNERGY Outcomes)
2025-522674-36-00 — liver diseases, liver
Phase 3Recruiting2026
Long term Follow up of the Offspring Born to Mothers With a Solid Organ Transplant Transplantlines Next Generation
NCT07291258 — kidney diseases, quality of life, liver transplantation, pregnancy, lung, mothers, blood, parturition, heart, pancreas transplantation, kidney, liver, islets of langerhans transplantation, pancreas, heart transplantation, transplants, research, cardiovascular abnormalities, kidney transplantation, lung transplantation, organ transplantation, transplantation, child, adult children
N/ARecruiting2025
Non Invasive Portal and Hepatic Vein Pressure Estimation
NCT06210178 — liver diseases, research design, hypertension, portal pressure, blood, hepatic veins, portal vein, magnetic resonance imaging, liver, hypertension, portal, meals, veins
N/ARecruiting2023
The Clock Thickens Morning or Evening Training for the Treatment of NAFLD
NCT05987748 — liver diseases, exercise, circadian rhythm, non-alcoholic fatty liver disease, liver, alcoholics, therapeutics, fatty liver, fatty liver, alcoholic
N/ANot yet recruiting2023

LeadR Networks

Main global connection map